TRVX
Circio Holding ASA is a biotechnology company focused on developing circular RNA–based medicines and immunotherapy therapies. The company is advancing circular RNA expression systems and the circVec platform to enhance gene therapy for genetic diseases. Its operations encompass research, development, and clinical programs with investor and partnering activities highlighted on its website. Circio presents itself as a leader in deploying circular RNA technology to improve therapeutic outcomes in biotechnology and biopharma contexts.
No recent deals for this company.